GuideHaematology

A-HIPI: Advanced-stage Hodgkin Lymphoma International Prognostic Index

Reading sheet on the HoLISTIC model estimating 5-year PFS and OS in advanced-stage classic Hodgkin lymphoma in adults aged 18–65.

Updated 3 November 2026

When to use it

Adults aged 18–65 with newly diagnosed advanced-stage classic Hodgkin lymphoma (IIB, III or IV) receiving standard chemotherapy; it replaces the IPS as an individual risk estimate.

What it is and for whom

Cox model developed by the HoLISTIC consortium from 4,022 patients in 8 phase III trials (1996–2014) and externally validated in 1,431 patients from 4 registries. It estimates individual 5-year PFS and OS probabilities in advanced classic Hodgkin lymphoma treated with standard chemotherapy (ABVD, BEACOPP and variants).

Keep reading in the app

  • Variables
  • Interpretation
  • Limitations

Practical tip

It uses continuous variables (age and lymphocytes with non-linear effects) instead of the IPS dichotomous cut-offs: better calibration and better discrimination for OS.

2 more practical tips in the app.

Reference

Official source: A-HIPI risk-group tool (HoLISTIC / Mayo Clinic)

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top